Literature DB >> 12360216

Anti-inflammatory lipid mediators and insights into the resolution of inflammation.

Toby Lawrence1, Derek A Willoughby, Derek W Gilroy.   

Abstract

The pro-inflammatory signalling pathways and cellular mechanisms that initiate the inflammatory response have become increasingly well characterized. However, little is known about the mediators and mechanisms that switch off inflammation. Recent data indicate that the resolution of inflammation is an active process controlled by endogenous mediators that suppress pro-inflammatory gene expression and cell trafficking, as well as induce inflammatory-cell apoptosis and phagocytosis, which are crucial determinants of successful resolution. This review focuses on this emerging area of inflammation research and describes the mediators and mechanisms that are currently stealing the headlines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12360216     DOI: 10.1038/nri915

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  220 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

Review 2.  Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics.

Authors:  Charles N Serhan; Bruce Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

Review 3.  Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications.

Authors:  Saba Aïd; Francesca Bosetti
Journal:  Biochimie       Date:  2010-09-22       Impact factor: 4.079

4.  Alpinia katsumadai H(AYATA) seed extract inhibit LPS-induced inflammation by induction of heme oxygenase-1 in RAW264.7 cells.

Authors:  Mee-Young Lee; Chang-Seob Seo; Jin-Ah Lee; In-Sik Shin; Su-Jeong Kim; HeyKyung Ha; Hyeun-Kyoo Shin
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

5.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

6.  Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.

Authors:  Ravindra Rajakariar; Justine Newson; Edwin K Jackson; Precilla Sawmynaden; Andrew Smith; Farooq Rahman; Muhammad M Yaqoob; Derek W Gilroy
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 7.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 8.  Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.

Authors:  A E Leitch; C Haslett; A G Rossi
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 9.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

10.  Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer.

Authors:  Junguee Lee; Shinae Yi; Minho Won; Young Shin Song; Hyon-Seung Yi; Young Joo Park; Ki Cheol Park; Jung Tae Kim; Joon Young Chang; Min Joung Lee; Hae Joung Sul; Ji Eun Choi; Koon Soon Kim; Jukka Kero; Joon Kim; Minho Shong
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.